Testing a new ointment in healthy volunteers
This early-stage study tests a new ointment (YR001) on healthy volunteers to see how it is absorbed through the skin and how safe it is. It helps researchers understand how the ointment behaves in the body before it is tested in people with skin conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy adult between 18 and 65 years old.
- You weigh at least 50 kg (110 lbs) and have a body mass index between 18 and 30.
- The skin where the ointment is applied must be healthy, with no cuts, rashes, tattoos, or sunburn.
- You must agree to use effective birth control during the study and for 3 months after it ends.
- You cannot be pregnant or breastfeeding.
- You must be willing to avoid using creams or wax on the test area for 2 weeks before and during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an ointment called MH004 to see if it helps repigment white patches in people with non-segmental vitiligo (the most common type). It focuses on patches on the face and body.
This study tests a new ointment called ENC0653 in healthy adults to see if it is safe and how it works in the body. It is the first time this ointment is being tested in people, so if you are healthy and your skin is clear, you may be able to help.
This trial tests a new ointment called CU-10101. It will first be tested in healthy volunteers to check safety, and then in people with atopic dermatitis (eczema) to see how well it works for mild to moderate symptoms.
This study tests a new investigational drug, called HRS-8797, in healthy people to see how safe it is and how the body processes it. It's an early-phase trial, so you may not directly benefit, but your participation can help find new treatments for future patients.
This study tests a new ointment called IN-115314 for adults with mild to moderate eczema. Researchers want to see if it helps control symptoms like itching and redness better than a placebo, and check that it's safe to use.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
Hear when a new Health Adult Subjects trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.